BullBD Old Apps Site
Home
Details Chart Today news Share news Top gainer Top Looser Upcoming events
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 0 1 2 3 4 5 6 7 8 9 All
Bank Cement Ceramics Sector Corporate Bond Engineering Financial Institutions Food & Allied Fuel & Power IT Sector Insurance Jute Life Insurance Miscellaneous Mutual Funds Paper & Printing Pharmaceuticals & Chemicals Services & Real Estate Tannery Industries Telecommunication Textile Travel & Leisure All
  • Details
  • Chart
  • News

ORIONPHARM

All Eps Dividend Board Agm Q1 Q2 Q3

ORIONPHARM 09-Nov-2021

As per Regulation 16(1) of the Dhaka Stock Exchange (Listing) Regulations, 2015, the Company has informed that a meeting of the Board of Directors will be held on November 14, 2021 at 4:00 PM to consider, among others, un-audited financial statements of the Company for the First Quarter (Q1) period ended on September 30, 2021.

ORIONPHARM 09-Nov-2021

There will be no price limit on the trading of the shares of the Company today (09.11.2021) following its corporate declaration.

ORIONPHARM 09-Nov-2021

(Continuation news of ORIONPHARM): The Company has reported Consolidated EPS of Tk. 4.01, Consolidated NAV per share (Including Revaluation Surplus) of Tk. 79.76, Consolidated NAV per share (Excluding Revaluation Surplus) of Tk. 71.79 and Consolidated NOCFPS of Tk. 11.07 for the year ended on June 30, 2021 as against Tk. 2.84, Tk. 76.77, Tk. 68.69 and Tk. 8.04 respectively for the same period of the previous year. (end)

ORIONPHARM 09-Nov-2021

The Board of Directors has recommended 12% cash dividend for the year ended on June 30, 2021. The Board has also considered and recommended the proposal for approval of the shareholders regarding Related Party Transaction for the Financial year ended June 30, 2021 and in this regard, the Board also advised to convene an EGM. Date of AGM and EGM: 19.12.2021, Time of AGM and EGM: 3:00 PM and 3:45 PM respectively, Venue: Digital Platform. Record Date for AGM and EGM: 29.11.2021. (Cont.)

ORIONPHARM 02-Nov-2021

As per Regulation 19(1) of the Dhaka Stock Exchange (Listing) Regulations, 2015, the Company has informed that a meeting of the Board of Directors will be held on November 08, 2021 at 4:00 PM to consider, among others, audited financial statements of the Company for the year ended on June 30, 2021.

ORIONPHARM 06-Oct-2021

In response to a DSE query dated October 04, 2021, the Company has informed that there is no undisclosed price sensitive information of the Company for recent unusual price hike and increase in volume of shares.

ORIONPHARM 12-Sep-2021

(Continuation news of ORIONPHARM): But as per our knowledge and understanding, no such proposal was placed or approved on that Cabinet Meeting. Therefore, this news article holds no credibility and we believe that a vested group is spreading such rumors in order to influence the Share Market of Bangladesh."

ORIONPHARM 12-Sep-2021

In response to a DSE query dated September 08, 2021, regarding clarification on recent news published in the newspaper, the Company has informed that "According to the news article, on September 06, 2021 the Cabinet gave Approval in Principle and Final Approval to extend the Quick Enhancement of Electricity and Energy Supply (Special Provision) Act 2010. (cont.)

ORIONPHARM 05-Jul-2021

(Continuation news of ORIONPHARM): Consolidated NAV per share (excluding Revaluation Surplus) was Tk. 70.79 as on March 31, 2021 and Tk. 68.69 as on June 31, 2020. NAV per share (including Revaluation Surplus) was Tk. 78.78 as on March 31, 2021 and Tk. 76.77 as on June 31, 2020. (end)

ORIONPHARM 05-Jul-2021

(Q3 Un-audited): Consolidated EPS was Tk. 0.95 for January-March 2021 as against Tk. 0.61 for January-March 2020; Consolidated EPS was Tk. 2.98 for July 2020-March 2021 as against Tk. 2.75 for July 2019-March 2020. Consolidated NOCFPS was Tk. 7.52 for July 2020-March 2021 as against Tk. 2.73 for July 2019-March 2020. (cont.)

Previous Next page